Hirsch Andrew (CIK 0001586707)

Latest company ownership

Shares held
335,300
Last filed at
Feb 18, 2025
Confidence Score
50.5
2025Q4
Confidence Score History
2022Q2 2025Q4
Shares held
5,893
Last filed at
Apr 24, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 14, 2025 Feb 18, 2025 C4 Therapeutics, Inc. CEO Sell 95.0 +201,283 90.72% ✗ $70.7K
Nov 7, 2024 Nov 12, 2024 C4 Therapeutics, Inc. CEO Sell 46.3 -5,550 -2.44% ✗ $33.5K
Sep 16, 2024 Sep 17, 2024 C4 Therapeutics, Inc. CEO Sell 46.3 -3,329 -1.53% ✗ $21.2K
Feb 15, 2024 Feb 15, 2024 C4 Therapeutics, Inc. CEO Sell 42.5 -6,560 -3.02% ✗ $51.8K
Aug 30, 2023 Aug 31, 2023 C4 Therapeutics, Inc. CEO Sell 47.5 -2,205 -1.90% ✗ $6.5K
Jan 30, 2023 Feb 1, 2023 C4 Therapeutics, Inc. CEO Sell 46.3 -4,319 -13.79% ✗ $33.6K
May 26, 2022 Jun 14, 2022 C4 Therapeutics, Inc. CEO Sell 46.3 -3,675 -16.33% ✗ $25.8K
Apr 12, 2022 Apr 12, 2022 C4 Therapeutics, Inc. CEO Buy 95.0 +10,000 100.00% ✗ $84K
Apr 22, 2020 Apr 24, 2020 AGIOS PHARMACEUTICALS, INC. CFO Sell 22.5 -1,927 -7.36% ✗ $88.5K
Apr 13, 2020 Apr 15, 2020 AGIOS PHARMACEUTICALS, INC. CFO Sell 22.5 -1,599 -7.30% ✗ $65K
Feb 22, 2020 Feb 25, 2020 AGIOS PHARMACEUTICALS, INC. CFO Sell 22.5 -1,056 -6.01% ✗ $51.4K
Feb 16, 2020 Feb 19, 2020 AGIOS PHARMACEUTICALS, INC. CFO Sell 26.3 -886 -5.86% ✗ $46.1K
Feb 16, 2019 Feb 20, 2019 AGIOS PHARMACEUTICALS, INC. CFO Sell 26.3 -821 -6.22% ✗ $47.6K
Jan 20, 2019 Jan 23, 2019 AGIOS PHARMACEUTICALS, INC. CFO Sell 22.5 -4,555 -30.37% ✗ $240.6K